doi: 10.1111/dth.15646.
Epub 2022 Jun 29.
Omalizumab as adjuvant therapy for pemphigus vulgaris
Affiliations
- PMID: 35716013
- DOI: 10.1111/dth.15646
Item in Clipboard
Omalizumab as adjuvant therapy for pemphigus vulgaris
Dermatol Ther.
2022 Aug.
No abstract available
Similar articles
-
Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.Am J Clin Dermatol. 2007;8(2):85-92. doi: 10.2165/00128071-200708020-00004. Am J Clin Dermatol. 2007. PMID: 17428113
-
Nail unit involvement during severe initial pemphigus vulgaris development.Eur J Dermatol. 2009 May-Jun;19(3):290-1. doi: 10.1684/ejd.2009.0664. Epub 2009 Mar 3. Eur J Dermatol. 2009. PMID: 19258233 No abstract available.
-
Unilesional pemphigus vulgaris of the scalp after cochlear implantation.Am J Otolaryngol. 2011 Jan-Feb;32(1):80-1. doi: 10.1016/j.amjoto.2009.09.007. Epub 2009 Oct 31. Am J Otolaryngol. 2011. PMID: 20015813 No abstract available.
-
Pemphigus: a brief review.Clin Med (Lond). 2009 Aug;9(4):371-5. doi: 10.7861/clinmedicine.9-4-371. Clin Med (Lond). 2009. PMID: 19728517 Free PMC article. Review. No abstract available.
-
Pemphigus vulgaris: a therapeutic option for disease control.Gen Dent. 2008 Nov-Dec;56(7):700-3. Gen Dent. 2008. PMID: 19014030 Review.
Cited by
-
Self-reactive IgE and anti-IgE therapy in autoimmune diseases.Front Pharmacol. 2023 Jan 23;14:1112917. doi: 10.3389/fphar.2023.1112917. eCollection 2023. Front Pharmacol. 2023. PMID: 36755957 Free PMC article. Review.
-
Pruritus Is Associated with an Increased Risk for the Diagnosis of Autoimmune Skin Blistering Diseases: A Propensity-Matched Global Study.Biomolecules. 2023 Mar 6;13(3):485. doi: 10.3390/biom13030485. Biomolecules. 2023. PMID: 36979421 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
